#syntheticthc

U.K. company GW Pharmaceuticals Plc, provided “substantial evidence” of the drug’s [Epidiolex] effectiveness, FDA staff said. The medication [is now FDA approved to] treat seizures associated with two rare forms of epilepsy that typically affect children. …the medication appears to have an increased risk of liver injury. … GW Pharmaceuticals is really part of a conglomeration of international…